Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 398 | 0 | 0 |
| Gross Profit | N/A | N/A | 398 | N/A | N/A |
| Operating Expenses | 9,085 | 11,051 | 22,694 | 22,639 | 21,563 |
| Operating Income | -9,085 | -11,051 | -22,296 | -22,639 | -21,563 |
| Interest Expense | 683 | 745 | 444 | 0 | 0 |
| Other Income | -20 | 2 | 7 | -31 | 9 |
| Pre-tax Income | -9,788 | -11,794 | -22,733 | -22,670 | -21,554 |
| Net Income Continuous | -9,788 | -11,794 | -22,733 | -22,670 | -21,554 |
| Net Income | $-9,788 | $-11,794 | $-22,733 | $-22,670 | $-21,554 |
| EPS Basic Total Ops | -7.50 | -7.50 | -16.49 | -16.49 | -14.99 |
| EPS Basic Continuous Ops | -6.83 | -8.23 | -15.89 | -15.85 | -15.10 |
| EPS Diluted Total Ops | -7.50 | -7.50 | -16.49 | -16.49 | -14.99 |
| EPS Diluted Continuous Ops | -6.83 | -8.23 | -15.89 | -15.85 | -15.10 |
| EBITDA(a) | $-8,198 | $-10,111 | $-21,475 | $-21,960 | $-21,023 |